Canadian Corporate Innovation Summit
V. Kadir Kadhiresan, PhD
Vice President, Venture Investments, Johnson & Johnson Development Corporation (JJDC)
Dr. Kadhiresan has more than a decade of operational experience in various functional roles including research, product development and business development.
Before joining JJDC, as head of Business Development at Guidant, Inc., (now Boston Scientific Inc.) Dr. Kadhiresan led several transactions to access novel medical device technologies with venture investments, M&As, licensing and joint ventures.
Prior to entering business development, he led the research and development of multiple early-stage technologies and products in cardiac rhythm management and heart failure. Dr. Kadhiresan was instrumental in the development of the cardiac resynchronization therapy for heart failure, now a multi-billion dollar worldwide market. At Heart Rhythm Technologies, a subsidiary of Guidant, he led the development of an ablation technology for treatment of atrial fibrillation and raised venture financing for the project. In addition, Dr. Kadhiresan is an inventor on more than 40 patents and has published several articles in peer-reviewed journals.
Dr. Kadhiresan received a PhD and Master of Science in Biomedical Engineering from the University of Michigan, Ann Arbor; a Master of Business Administration from the Kellogg School of Management at Northwestern University; and a Bachelor of Science in Electrical Engineering from the National Institute of Technology (REC), Trichy, India.